Latest Conference Articles

ACOG 2025: Steven Fleischman, MD, Inaugurated as 76th President, Urges New Fellows to Lead with Purpose

ACOG 2025: Steven Fleischman, MD, Inaugurated as 76th President, Urges New Fellows to Lead with Purpose

May 17th 2025

ACOG

Steven Fleischman, MD, was inaugurated as ACOG’s 76th president, urging new fellows to lead with purpose and recognize their value in women’s health care.

Primary Care Falls Short in Managing Adolescent Heavy Menstrual Bleeding, Researchers Warn

Primary Care Falls Short in Managing Adolescent Heavy Menstrual Bleeding, Researchers Warn

May 17th 2025

ACOG

Fewer than half of young girls who experienced heavy menstrual bleeding were given hormonal treatment and far fewer were referred to gynecology, authors reported.

GLP1-RAs Superior to Metformin for CVD Risk Reduction in Women with PCOS, Large Study Finds

GLP1-RAs Superior to Metformin for CVD Risk Reduction in Women with PCOS, Large Study Finds

May 17th 2025

ACOG

The findings support the potential cardiovascular advantages of the GLP-1RA class in women with PCOS, a population already at increased cardiometabolic risk.

Study Identifies 6 Components of a Pregnancy Exercise Program that Reduce Risk of Poor Perinatal Outcomes

Study Identifies 6 Components of a Pregnancy Exercise Program that Reduce Risk of Poor Perinatal Outcomes

May 17th 2025

ACOG

While exercise is beneficial during pregnancy and ACOG recommends 150 mins/week, this is the first study to examine benefits of specific regimen elements on their own.

Fezolinetant Demonstrates Reduced Waist Circumference, Body Roundness and Stable Weight and BMI in 52-Week Pooled Analysis of Phase 3 SKYLIGHT Trials

Fezolinetant Demonstrates Reduced Waist Circumference, Body Roundness and Stable Weight and BMI in 52-Week Pooled Analysis of Phase 3 SKYLIGHT Trials

May 17th 2025

ACOG

Postmenopausal women taking fezolinetant experienced positive changes in body fat distribution, increases in which are known to increase risks of cardiometabolic disease.

ACOG 2025: Poster Highlights for Primary Care

ACOG 2025: Poster Highlights for Primary Care

May 16th 2025

ACOG

Details on 12 key abstracts with clinical relevance for primary care, from menopause management to PPD screening and HPV testing.

Elinzanetant Demonstrates Clinically Meaningful Reductions in Menopausal Vasomotor Symptoms, Meta-analysis Shows

Elinzanetant Demonstrates Clinically Meaningful Reductions in Menopausal Vasomotor Symptoms, Meta-analysis Shows

May 16th 2025

ACOG

Elinzanetant reduced VMS frequency and intensity, and improved sleep and quality of life, according to the meta-analysis to be presented at the ACOG 2025 meeting.

The Role of Primary Care in Women's Health With Laurence Shields, MD

The Role of Primary Care in Women's Health With Laurence Shields, MD

May 16th 2025

ACOG

The two areas where primary care physicians can contribute to improving women's health, according to Laurence Shields, MD.

ACOG 2025 Refresh: Menopausal VMS Education in Primary Care

ACOG 2025 Refresh: Menopausal VMS Education in Primary Care

May 16th 2025

ACOG

Building trust with patients early on will help them feel comfortable discussing their symptoms and treatment preferences, says JoAnn Pinkerton, MD.